Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Ligand Pharmaceuticals Inc (LGND)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Dorset Management

David M. Knott

344,041 $43,250 17.23%
2.
Cardinal Capital

Amy Minella

882,515 $110,941 +75% 3.68%
3. 5,889 $740 -2% 0.85%
4.
Opus Point Partners Management

Michael S. Weiss And Lindsay A. Rosenwald

1,745 $219 0.29%
5. 1,415,708 $177,969 -5% 0.16%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$107.01 250 Director 61,703 2019-06-11 Filing
$108.20 1,000 Officer, Director 144,899 2019-05-31 Filing
$108.51 500 Director 60,618 2019-05-31 Filing
$110.01 250 Director 60,118 2019-05-30 Filing
$111.01 250 Director 59,868 2019-05-29 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$112.92 2,500 Director 25,542 2019-05-14 Filing
$253.99 2,500 Director 42,556 2018-10-08 Filing
$275.04 2,500 Director 26,142 2018-10-01 Filing
$273.88 12,000 Officer 105,388 2018-10-01 Filing
$250.69 2,813 Officer 27,763 2018-09-17 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 25,000 $3,143 12.1%
2. 150,000 $18,857 10.84%
3. 621,006 $78,067 2.17%
4. 131,559 $16,538 2.14%
5. 30,505 $3,835 2.08%
News See All